TY - JOUR AU - Dodick, D. W. AU - Lipsy, R. PY - 2004 DA - 2004// TI - Advances in migraine management: implications for managed care organizations JO - Manag Care VL - 13 ID - Dodick2004 ER - TY - STD TI - Tepper S, Tepper D. How do I do it reference for the acute treatment of migraine. Am Headache Soc. 2008; https://americanheadachesociety.org/wp-content/uploads/2018/05/How_I_Do_It_Acute_Treatment.pdf. UR - https://americanheadachesociety.org/wp-content/uploads/2018/05/How_I_Do_It_Acute_Treatment.pdf ID - ref2 ER - TY - JOUR AU - Cameron, C. AU - Kelly, S. AU - Hsieh, S. C. AU - Murphy, M. AU - Chen, L. AU - Kotb, A. PY - 2015 DA - 2015// TI - Triptans in the acute treatment of migraine: a systematic review and network meta-analysis JO - Headache VL - 55 UR - https://doi.org/10.1111/head.12601 DO - 10.1111/head.12601 ID - Cameron2015 ER - TY - JOUR AU - Ferrari, M. D. AU - Roon, K. I. AU - Lipton, R. B. AU - Goadsby, P. J. PY - 2001 DA - 2001// TI - Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06711-3 DO - 10.1016/S0140-6736(01)06711-3 ID - Ferrari2001 ER - TY - JOUR AU - Vila-Pueyo, M. PY - 2018 DA - 2018// TI - Targeted 5-HT1F therapies for migraine JO - Neurotherapeutics VL - 15 UR - https://doi.org/10.1007/s13311-018-0615-6 DO - 10.1007/s13311-018-0615-6 ID - Vila-Pueyo2018 ER - TY - JOUR AU - Kuca, B. AU - Silberstein, S. D. AU - Wietecha, L. AU - Berg, P. H. AU - Dozier, G. AU - Lipton, R. B. PY - 2018 DA - 2018// TI - Lasmiditan is an effective acute treatment for migraine: a phase 3 randomized study JO - Neurology VL - 91 UR - https://doi.org/10.1212/WNL.0000000000006641 DO - 10.1212/WNL.0000000000006641 ID - Kuca2018 ER - TY - JOUR AU - Goadsby, P. J. L. L. AU - Dennehy, E. B. AU - Kuca, B. AU - Case, M. G. AU - Aurora, S. K. AU - Gaul, C. PY - 2019 DA - 2019// TI - Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine JO - Brain VL - 142 UR - https://doi.org/10.1093/brain/awz134 DO - 10.1093/brain/awz134 ID - Goadsby2019 ER - TY - BOOK PY - 2017 DA - 2017// TI - Clinical Trials in Alzheimer’s Disease ID - ref8 ER - TY - JOUR AU - Diener, H. a. n. s. -. C. h. r. i. s. t. o. p. h. AU - Tassorelli, C. r. i. s. t. i. n. a. AU - Dodick, D. a. v. i. d. W. AU - Silberstein, S. t. e. p. h. e. n. D. AU - Lipton, R. i. c. h. a. r. d. B. AU - Ashina, M. e. s. s. o. u. d. AU - Becker, W. e. r. n. e. r. J. AU - Ferrari, M. i. c. h. e. l. D. AU - Goadsby, P. e. t. e. r. J. AU - Pozo-Rosich, P. a. t. r. i. c. i. a. AU - Wang, S. h. u. u. -. J. i. u. n. AU - Mandrekar, J. a. y. PY - 2019 DA - 2019// TI - Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition JO - Cephalalgia VL - 39 UR - https://doi.org/10.1177/0333102419828967 DO - 10.1177/0333102419828967 ID - Diener2019 ER - TY - JOUR AU - Diamond, M. L. AU - Hettiarachchi, J. AU - Hilliard, B. AU - Sands, G. AU - Nett, R. PY - 2004 DA - 2004// TI - Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders JO - Headache VL - 44 UR - https://doi.org/10.1111/j.1526-4610.2004.04049.x DO - 10.1111/j.1526-4610.2004.04049.x ID - Diamond2004 ER - TY - JOUR AU - Scott, R. J. AU - Aitchison, W. R. C. AU - Barker, P. R. AU - McLaren, G. I. PY - 1996 DA - 1996// TI - Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice JO - QJM VL - 89 UR - https://doi.org/10.1093/qjmed/89.8.613 DO - 10.1093/qjmed/89.8.613 ID - Scott1996 ER - TY - JOUR AU - Teall, J. AU - Tuchman, M. AU - Cutler, N. AU - Gross, M. AU - Willoughby, E. AU - Smith, B. PY - 1998 DA - 1998// TI - Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 study group JO - Headache VL - 38 UR - https://doi.org/10.1046/j.1526-4610.1998.3804281.x DO - 10.1046/j.1526-4610.1998.3804281.x ID - Teall1998 ER - TY - JOUR AU - Ferrari, M. D. AU - James, M. H. AU - Bates, D. AU - Pilgrim, A. AU - Ashford, E. AU - Anderson, B. A. PY - 1994 DA - 1994// TI - Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences JO - Cephalalgia VL - 14 UR - https://doi.org/10.1046/j.1468-2982.1994.1405330.x DO - 10.1046/j.1468-2982.1994.1405330.x ID - Ferrari1994 ER - TY - JOUR AU - Pfaffenrath, V. AU - Cunin, G. AU - Sjonell, G. AU - Prendergast, S. PY - 1998 DA - 1998// TI - Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan JO - Headache VL - 38 UR - https://doi.org/10.1046/j.1526-4610.1998.3803184.x DO - 10.1046/j.1526-4610.1998.3803184.x ID - Pfaffenrath1998 ER - TY - JOUR AU - Loo, L. AU - Plato, B. M. AU - Turner, I. M. AU - Case, M. G. AU - Raskin, J. AU - Dowsett, S. A. AU - Krege, J. H. PY - 2019 DA - 2019// TI - Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SUMURAI and SPARTAN) JO - Headache VL - 59 UR - https://doi.org/10.1111/head.13549 DO - 10.1111/head.13549 ID - Loo2019 ER -